Not Yet RecruitingNot Applicable

Depression Among Cardiothoracic Surgery Patients in Baghdad

Iraq200 participantsStarted 2025-04-20

Plain-language summary

This observational study aims to estimate the prevalence and severity of depression among patients in the Cardiothoracic Surgery Ward in Baghdad City, Iraq, using a self-administered PHQ-9 questionnaire. The main questions it aims to answer are: What is the prevalence of depression among cardiothoracic surgery patients? How is the severity of depression distributed within this group? Are there specific environmental or demographic factors associated with higher levels of depression? Participants will: Fill out the PHQ-9 in order to measure the severity of depressive symptoms at a specific moment in time. Demographic and clinical variables such as age, gender, socioeconomic status, surgery type, comorbidities, and hospital stay length should be taken to look for a possible relationship with depression.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to the cardiothoracic surgery ward. * Patients who are able to understand and provide informed consent. * Patients who have the cognitive ability to complete the PHQ-9 questionnaire. Exclusion Criteria: * Patients with a history of diagnosed psychiatric disorders other than depression. * Patients who are critically ill or in a life-threatening condition and unable to participate. * Patients who are unable to understand the PHQ-9 questionnaire due to language or cognitive barriers.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Prevalence of Depression

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.

Severity of Depression

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.

Patient Health Questionnaire-9 (PHQ-9)

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.

Trial details

NCT IDNCT06734169

SponsorAl-Nahrain University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-01

Contact for this trial

Abdul-Ilah R. Khamis

+9647838571013 allaabed987@ced.nahrainuniv.edu.iq

View on ClinicalTrials.gov More Depression trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Prevalence of Depression

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.

Severity of Depression

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.

Patient Health Questionnaire-9 (PHQ-9)

Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.